These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 37580184

  • 1. Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients.
    Pan SW, Catanzaro DG, Seifert M, Syed RR, Hillery N, Ho ML, Crudu V, Tudor E, Ciobanu N, Codreanu A, Catanzaro A, Rodwell TC.
    J Microbiol Immunol Infect; 2023 Oct; 56(5):1073-1083. PubMed ID: 37580184
    [Abstract] [Full Text] [Related]

  • 2. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S, Pallarès N, Grijota-Camino MD, Sánchez-Montalvá A, Barcia L, Campos-Gutiérrez S, Pomar V, Rabuñal-Rey R, Balcells ME, Gazel D, Montiel N, Vicente D, Goić-Barišić I, Schön T, Paues J, Mareković I, Cacho-Calvo J, Barac A, Goletti D, García-Gasalla M, Barcala JM, Tórtola MT, Anibarro L, Suárez-Toste I, Moga E, Gude-Gonzalez MJ, Naves R, Karslıgil T, Martin-Peñaranda T, Stevanovic G, Trigo M, Rubio V, Karaoğlan İ, Bayram N, Alcaide F, Tebé C, Santin M, ESCMID Study Group for Mycobacterial Infections (ESGMYC) and the Mycobacteria Study Group (GEIM) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
    Microbiol Spectr; 2021 Dec 22; 9(3):e0097221. PubMed ID: 34756079
    [Abstract] [Full Text] [Related]

  • 3. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M, Igari H, Okada N, Suzuki K.
    J Infect Chemother; 2020 Jun 22; 26(6):570-574. PubMed ID: 32067903
    [Abstract] [Full Text] [Related]

  • 4. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM.
    Eur Respir J; 2016 Nov 22; 48(5):1411-1419. PubMed ID: 27390280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J, Aksamit TR, Escalante P.
    J Clin Microbiol; 2018 Jul 22; 56(7):. PubMed ID: 29743310
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, Ippolito G, Goletti D.
    Tuberculosis (Edinb); 2017 Sep 22; 106():38-43. PubMed ID: 28802403
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting.
    Wikell A, Jonsson J, Dyrdak R, Henningsson AJ, Eringfält A, Kjerstadius T, Hålldin E, Baqir H, Kholod V, Sturegård E, Bruchfeld J, Schön T.
    J Clin Microbiol; 2021 Nov 18; 59(12):e0137021. PubMed ID: 34550805
    [Abstract] [Full Text] [Related]

  • 13. Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis.
    Darmawan G, Liman LMS, Hamijoyo L, Atik N, Alisjahbana B, Sahiratmadja E.
    Clin Chem Lab Med; 2023 Nov 27; 61(12):2067-2075. PubMed ID: 37221870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease.
    Fukushima K, Akagi K, Kondo A, Kubo T, Sakamoto N, Mukae H.
    Pulmonology; 2022 Nov 27; 28(1):6-12. PubMed ID: 34362702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study.
    Soler-Garcia A, Gamell A, Pérez-Porcuna T, Soriano-Arandes A, Santiago B, Tórtola T, Ruiz-Serrano MJ, Korta Murua JJ, Bustillo-Alonso M, Garrote-Llanos MI, Rodríguez-Molino P, Piqueras AI, Tagarro A, Monsonís M, Tebruegge M, Noguera-Julian A, QFT-Plus Study Group of the Spanish Pediatric TB Research Network.
    Thorax; 2022 Dec 27; 77(12):1193-1201. PubMed ID: 34876500
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.